INTS : Recherche

DPC

Documentation & publications

Service QRE

Sang & Transfusion sanguine

Europe & International

INTS in English

Votre recherche : [La BTT] AUTEUR égal Blajchman MA
58 résultat(s)

page 1/3

Blajchman MA, Carson JL, Eikelboom JW, Heddle NM, Lacroix J, Lauer MS, Platt R, Tilley B, Triulzi D, Vickers AJ, Yusuf S, Glynn S, Mondoro TH, Wagner E. The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop. Transfusion. 2012;52:1363-1378.
Thèmes : Hémovigilance et sécurité transfusionnelle ; maj-2012-11

Josephson CD, Glynn SA, Kleinman SH, Blajchman MA. A multidisciplinary "think tank": the top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium. Transfusion. 2011;51:828-841.
Thèmes : Histoire - Economie - Prospective ; maj-2011-11

Lacroix J, Hebert P, Fergusson D, Tinmouth A, Blajchman MA, Callum J, Cook D, Marshall JC, McIntyre L, Turgeon AF. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev. 2011;25:197-205.
Thèmes : Transfusion homologue ; Produits sanguins érythrocytaires ; Hémovigilance et sécurité transfusionnelle ; maj-2012-02

Leach Bennett J, Blajchman MA, Delage G, Fearon M, Devine D. Proceedings of a consensus conference: Risk-Based Decision Making for Blood Safety. Transfus Med Rev. 2011;25:267-292.
Thèmes : Aspects réglementaires et management en transfusion ; maj-2012-02

Barros MM, Blajchman MA, Bordin JO. Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment. Transfus Med Rev. 2010;24:195-210.
Thèmes : Auto-immunisation ; maj-2010-11

Blajchman MA, Glynn SA, Josephson CD, Kleinman SH. Clinical trial opportunities in Transfusion Medicine: proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium. Transfus Med Rev. 2010;24:259-285.
Thèmes : Aspects réglementaires et management en transfusion ; maj-2012-02

Vamvakas EC, Blajchman MA. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev. 2010;24:77-124.
Thèmes : Complications immunologiques ; Hémovigilance et sécurité transfusionnelle ; maj-2010-11

Voss CY, Fry TJ, Coppes MJ, Blajchman MA. Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis. Transfus Med Rev. 2010;24:22-32.
Thèmes : Immunologie fondamentale ; Plasmaphérèse - Echange plasmatique ; maj-2010-04

Ainsworth CD, Crowther MA, Treleaven D, Evanovitch D, Webert KE, Blajchman MA. Severe hemolytic anemia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review. Transfus Med Rev. 2009;23:155-159.
Thèmes : Transplantation ; Allo-immunisation - MHNN ; maj-2009-10

Blajchman MA. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Clin Biol. 2009;16:70-74.
Thèmes : maj-2009-10 ; Inactivation des pathogènes

Fergusson D, Hutton B, Hogan DL, LeBel L, Blajchman MA, Ford JC, Hebert P, Kakadekar A, Kovacs L, Lee S, Sankaran K, Shapiro S, Smyth JA, Ramesh K, Bouali NR, Tinmouth A, Walker R. The age of red blood cells in premature infants (ARIPI) randomized controlled trial: study design. Transfus Med Rev. 2009;23:55-61.
Thèmes : Hématologie fondamentale ; Transfusion homologue ; Produits sanguins érythrocytaires ; maj-2009-04

Klein HG, Glynn SA, Ness PM, Blajchman MA. Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop. Transfusion. 2009;49:1262-1268.
Thèmes : maj-2009-10 ; Inactivation des pathogènes

Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113:3406-3417.
Thèmes : Hémovigilance et sécurité transfusionnelle ; maj-2009-10

Blajchman MA. Platelet transfusions: an historical perspective. 2008;197.
Thèmes : Produits sanguins plaquettaires ; maj-2009-10

Blajchman MA, Slichter SJ, Heddle NM, Murphy MF. New strategies for the optimal use of platelet transfusions. 2008;198-204.
Thèmes : Produits sanguins plaquettaires ; maj-2009-10

Clark DA, Gorczynski RM, Blajchman MA. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen. Transfusion. 2008;48:814-821.
Thèmes : Complications immunologiques ; maj-2008-08

Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussieres JS, Cote D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319-2331.
Thèmes : Thérapeutiques de substitution - Facteurs de croissance ; maj-2008-08

Webert KE, Cook RJ, Couban S, Carruthers J, Lee KA, Blajchman MA, Lipton JH, Brandwein JM, Heddle NM. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion. 2008;48:81-91.
Thèmes : Transfusion homologue ; maj-2008-04

Webert KE, Cserti CM, Hannon J, Lin Y, Pavenski K, Pendergrast JM, Blajchman MA. Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies. Transfus Med Rev. 2008;22:1-34.
Thèmes : Inactivation des pathogènes ; maj-2008-04

Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21:327-348.
Thèmes : Transfusion homologue ; Complications immunologiques ; maj-2008-01

Arnold DM, Heddle NM, Kulczycky M, Carruthers J, Sigouin C, Blajchman MA. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers. Transfusion. 2006;46:257-264.
Thèmes : Produits sanguins plaquettaires ; maj-2006-03

Blajchman MA, Vamvakas EC. The continuing risk of transfusion-transmitted infections. N Engl J Med. 2006;355:1303-1305.
Thèmes : Epidémiologie ; maj-2006-12

Allain JP, Bianco C, Blajchman MA, Brecher ME, Busch M, Leiby D, Lin L, Stramer S. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Med Rev. 2005;19:110-126.
Thèmes : Hémovigilance et sécurité transfusionnelle ; Inactivation des pathogènes ; maj-2005-10

Blajchman MA. Landmark studies that have changed the practice of transfusion medicine. Transfusion. 2005;45:1523-1530.
Thèmes : Transfusion homologue ; Histoire - Economie - Prospective ; maj-2005-10

Blajchman MA. Pioneers and pathfinders in transfusion medicine. Transfus Med Rev. 2005;19:1.
Thèmes : Histoire - Economie - Prospective ; maj-2005-05

page 1/3